MedPath

An observational study for Xin-Guan-1 formula in the treatment of novel coronavirus pneumonia (COVID-19)

Phase 1
Not yet recruiting
Conditions
novel coronavirus pneumonia (COVID-19)
Registration Number
ITMCTR2000002980
Lead Sponsor
Guangdong Provincial Hospital of Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Patients who meet the diagnostic criteria of Hubei Province pneumonia infected by novel coronavirus(2019-nCoV), and clinical classification of mild, moderate and severe were included.

Exclusion Criteria

?Allergic constitution, ie, allergic history to 2 or more kinds of medicine or food, or to the medicines of our study.
?Patients who do not agree with taking traditional Chinese medicine.

Study & Design

Study Type
Observational study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.